| Authors: |
Leus M; The Forum for Collaborative Research, Washington, DC, USA., Osakwe CE; The Forum for Collaborative Research, Washington, DC, USA., Adda D; World Hepatitis Alliance, Geneva, Switzerland; African Viral Hepatitis Advisory Group, Abuja, Nigeria; Centre for Initiative and Development (CFID), Taraba State, Nigeria., El-Sayed M; Department of Pediatrics, Ain Shams University, Cairo, Egypt., Hicks J; World Hepatitis Alliance, Geneva, Switzerland., Ibrahim Y; Hepatitis B Foundation, Doylestown, PA, USA., Matthews PC; The Francis Crick Institute, London, UK; Division of Infection and Immunity, University College London, London, UK; Department of Infectious Diseases, University College London Hospitals, London, UK., Ndembi N; Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa, Ethiopia; International Vaccine Institute, Africa Regional Office (IARO), Kigali, Rwanda., Owusu-Ansah T; Hepatitis Foundation of Ghana, Accra, Ghana., Spearman CW; Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Sonderup MW; Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Ward J; Coalition for Global Hepatitis Elimination, The Task Force for Global Health, Decatur, GA, USA., Schaefer R; The Forum for Collaborative Research, Washington, DC, USA., Miller V; The Forum for Collaborative Research, Washington, DC, USA. Electronic address: veronicam@berkeley.edu. |